2024-10-22 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and health insurance plans.

**1. Performance Comparison:**

CVS has underperformed the S&P 500 significantly. Its cumulative return of -34.25% pales in comparison to the S&P 500's 137.88%. This translates to a substantial divergence of -172.13, placing CVS in the bottom percentile of historical performance compared to the benchmark index.

**2. Recent Price Action:**

* **Closing Price:** $60.34
* **5-day Moving Average:** $64.3
* **20-day Moving Average:** $63.07
* **60-day Moving Average:** $59.76

The stock is currently trading below its 5-day, 20-day, and 60-day moving averages, suggesting a bearish trend in the short term.

**3. Technical Indicators:**

* **RSI:** 41.68 - The RSI suggests that the stock is currently in oversold territory, indicating potential for a rebound.
* **PPO:** -0.68 - The PPO indicates a bearish trend, but the relatively small value (-0.68) might signal that the downward pressure is not substantial.
* **Delta_Previous_Relative_Divergence:** -0.11 - The negative value indicates a recent decline in relative performance compared to the broader market.
* **Expected_Return:** 0.0% - This implies that the stock is not expected to outperform the S&P 500 in the long term.

**4. Recent Earnings and Outlook:**

| Date       | EPS | Expected EPS |
|------------|-----|--------------|
| 2024-08-07 | 1.83 | 1.73          |
| 2024-05-01 | 1.31 | 1.70          |
| 2024-02-07 | 2.12 | 2.01          |
| 2023-11-01 | 2.21 | 2.13          |
| 2023-08-02 | 2.21 | 2.12          |

CVS exceeded earnings expectations in the most recent quarter (2024-08-07), reporting EPS of 1.83 against an expected EPS of 1.73. However, the company's recent earnings have been inconsistent, with some quarters exceeding expectations and others falling short. The company is facing challenges in the healthcare industry, including rising costs and increased competition.

**5. News and Recent Issues:**

The recent market outlook for CVS is mixed. While some analysts remain optimistic about the company's long-term growth potential, others are concerned about its ability to navigate the current healthcare landscape. CVS's recent earnings beat and plans to expand its healthcare services have fueled some positive sentiment. However, the company is facing headwinds from rising inflation and increased competition from Amazon, Walmart, and other players entering the pharmacy and healthcare space.

**FINBOLD** reports that CVS is facing pressure to improve its operating efficiency, as its earnings are expected to remain under pressure due to rising costs and competition. The company's recent acquisition of Signify Health further expands its reach into the healthcare market.

**6. Comprehensive Analysis:**

CVS Health Corp is currently facing challenges in the healthcare industry. While its recent earnings beat offers some optimism, the company faces several headwinds, including rising costs and competition. The stock's underperformance compared to the S&P 500 and its recent decline in relative performance highlight the need for careful consideration before investing. Despite the stock being in oversold territory, the negative PPO and expected return suggest that the stock may not outperform the market in the long term.

**7. Conclusion:**

Based on the analysis of CVS's performance, technical indicators, and recent developments, it's recommended to approach this investment with caution. While the stock may offer some potential for short-term gains due to its oversold condition, its long-term prospects remain unclear due to the challenging healthcare environment and its history of underperforming the S&P 500. Further research and monitoring of the company's performance and market trends are recommended before making any investment decisions. 
